FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2976249548> ?p ?o ?g. }

• W2976249548 endingPage "36" @default.
• W2976249548 startingPage "24" @default.
• W2976249548 abstract "This study quantified the change in blood pressure (BP) during antivascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) therapy, compared BPs between TKIs, and analyzed change in BP during antihypertensive therapy.TKIs targeting VEGF are associated with hypertension. The absolute change in BP during anti-VEGF TKI treatment is not well characterized outside clinical trials.A retrospective single-center study included patients with metastatic renal cell carcinoma who received anti-VEGF TKIs between 2007 and 2018. Mixed models analyzed 3,088 BPs measured at oncology clinics.In 228 patients (baseline systolic blood pressure [SBP] 130.2 ± 16.3 mm Hg, diastolic blood pressure [DBP] 76.8 ± 9.3 mm Hg), anti-VEGF TKIs were associated with mean increases in SBP of 8.5 mm Hg (p < 0.0001) and DBP of 6.7 mm Hg (p <0.0001). Of the anti-VEGF TKIs evaluated, axitinib was associated with the greatest BP increase, with an increase in SBP of 12.6 mm Hg (p < 0.0001) and in DBP of 10.3 mm Hg (p < 0.0001) relative to baseline. In pairwise comparisons between agents, axitinib was associated with greater SBPs than cabozantinib by 8.4 mm Hg (p = 0.004) and pazopanib by 5.1 mm Hg (p = 0.01). Subsequent anti-VEGF TKI courses were associated with small increases in DBP, but not SBP, relative to the first course. During anti-VEGF TKI therapy, calcium-channel blockers and potassium-sparing diuretic agents were associated with the largest BP reductions, with decreases in SBP of 5.6 mm Hg (p < 0.0001) and 9.9 mm Hg (p = 0.007), respectively.Anti-VEGF TKIs are associated with increased BP; greatest increases are observed with axitinib. Calcium-channel blockers and potassium-sparing diuretic agents were associated with the largest reductions in BP." @default.
• W2976249548 created "2019-10-03" @default.
• W2976249548 creator A5010445417 @default.
• W2976249548 creator A5021084646 @default.
• W2976249548 creator A5038028521 @default.
• W2976249548 creator A5063789638 @default.
• W2976249548 creator A5084557946 @default.
• W2976249548 creator A5087836779 @default.
• W2976249548 date "2019-09-01" @default.
• W2976249548 modified "2023-10-03" @default.
• W2976249548 title "Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor" @default.
• W2976249548 cites W1512404644 @default.
• W2976249548 cites W1880435494 @default.
• W2976249548 cites W1947531983 @default.
• W2976249548 cites W1965024282 @default.
• W2976249548 cites W1979287092 @default.
• W2976249548 cites W1999966467 @default.
• W2976249548 cites W2003466422 @default.
• W2976249548 cites W2027671567 @default.
• W2976249548 cites W2028031291 @default.
• W2976249548 cites W2028262440 @default.
• W2976249548 cites W2030541189 @default.
• W2976249548 cites W2036735258 @default.
• W2976249548 cites W2038827789 @default.
• W2976249548 cites W2051137473 @default.
• W2976249548 cites W2051563676 @default.
• W2976249548 cites W2063544208 @default.
• W2976249548 cites W2073212944 @default.
• W2976249548 cites W2083684635 @default.
• W2976249548 cites W2088781488 @default.
• W2976249548 cites W2089902400 @default.
• W2976249548 cites W2099088585 @default.
• W2976249548 cites W2122956665 @default.
• W2976249548 cites W2125121492 @default.
• W2976249548 cites W2126125759 @default.
• W2976249548 cites W2149259234 @default.
• W2976249548 cites W2157769714 @default.
• W2976249548 cites W2159034771 @default.
• W2976249548 cites W2162424705 @default.
• W2976249548 cites W2164363535 @default.
• W2976249548 cites W2183880308 @default.
• W2976249548 cites W2293809486 @default.
• W2976249548 cites W2768267412 @default.
• W2976249548 cites W2792262692 @default.
• W2976249548 doi "https://doi.org/10.1016/j.jaccao.2019.08.012" @default.
• W2976249548 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8352203" @default.
• W2976249548 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34396159" @default.
• W2976249548 hasPublicationYear "2019" @default.
• W2976249548 type Work @default.
• W2976249548 sameAs 2976249548 @default.
• W2976249548 citedByCount "31" @default.
• W2976249548 countsByYear W29762495482020 @default.
• W2976249548 countsByYear W29762495482021 @default.
• W2976249548 countsByYear W29762495482022 @default.
• W2976249548 countsByYear W29762495482023 @default.
• W2976249548 crossrefType "journal-article" @default.
• W2976249548 hasAuthorship W2976249548A5010445417 @default.
• W2976249548 hasAuthorship W2976249548A5021084646 @default.
• W2976249548 hasAuthorship W2976249548A5038028521 @default.
• W2976249548 hasAuthorship W2976249548A5063789638 @default.
• W2976249548 hasAuthorship W2976249548A5084557946 @default.
• W2976249548 hasAuthorship W2976249548A5087836779 @default.
• W2976249548 hasBestOaLocation W29762495481 @default.
• W2976249548 hasConcept C126322002 @default.
• W2976249548 hasConcept C126894567 @default.
• W2976249548 hasConcept C134018914 @default.
• W2976249548 hasConcept C167734588 @default.
• W2976249548 hasConcept C170493617 @default.
• W2976249548 hasConcept C2776539811 @default.
• W2976249548 hasConcept C2777025900 @default.
• W2976249548 hasConcept C2777472916 @default.
• W2976249548 hasConcept C2778439243 @default.
• W2976249548 hasConcept C2779490328 @default.
• W2976249548 hasConcept C2781064419 @default.
• W2976249548 hasConcept C42362537 @default.
• W2976249548 hasConcept C71924100 @default.
• W2976249548 hasConcept C84393581 @default.
• W2976249548 hasConcept C98274493 @default.
• W2976249548 hasConceptScore W2976249548C126322002 @default.
• W2976249548 hasConceptScore W2976249548C126894567 @default.
• W2976249548 hasConceptScore W2976249548C134018914 @default.
• W2976249548 hasConceptScore W2976249548C167734588 @default.
• W2976249548 hasConceptScore W2976249548C170493617 @default.
• W2976249548 hasConceptScore W2976249548C2776539811 @default.
• W2976249548 hasConceptScore W2976249548C2777025900 @default.
• W2976249548 hasConceptScore W2976249548C2777472916 @default.
• W2976249548 hasConceptScore W2976249548C2778439243 @default.
• W2976249548 hasConceptScore W2976249548C2779490328 @default.
• W2976249548 hasConceptScore W2976249548C2781064419 @default.
• W2976249548 hasConceptScore W2976249548C42362537 @default.
• W2976249548 hasConceptScore W2976249548C71924100 @default.
• W2976249548 hasConceptScore W2976249548C84393581 @default.
• W2976249548 hasConceptScore W2976249548C98274493 @default.
• W2976249548 hasIssue "1" @default.
• W2976249548 hasLocation W29762495481 @default.
• W2976249548 hasLocation W29762495482 @default.
• W2976249548 hasOpenAccess W2976249548 @default.
• W2976249548 hasPrimaryLocation W29762495481 @default.

• next